Global Cord Blood Corporation Stock

Equities

CORB.F

KYG393421030

Healthcare Facilities & Services

Market Closed - OTC Markets 10:05:41 2024-04-19 am EDT 5-day change 1st Jan Change
1.25 USD 0.00% Intraday chart for Global Cord Blood Corporation 0.00% +2.46%
Sales 2021 1.16B 160M Sales 2022 1.24B 172M Capitalization 2.97B 410M
Net income 2021 508M 70.17M Net income 2022 501M 69.2M EV / Sales 2021 -2.13 x
Net cash position 2021 6.07B 839M Net cash position 2022 6.66B 920M EV / Sales 2022 -2.97 x
P/E ratio 2021
7.1 x
P/E ratio 2022
5.93 x
Employees 1,202
Yield 2021 *
-
Yield 2022
-
Free-Float 38.41%
More Fundamentals * Assessed data
Dynamic Chart
Current month-7.41%
1 month-16.67%
Current year+2.46%
More quotes
1 week
1.25
Extreme 1.25
1.25
1 month
1.25
Extreme 1.25
1.80
Current year
0.98
Extreme 0.9821
2.33
1 year
0.02
Extreme 0.021
2.33
3 years
0.02
Extreme 0.021
6.31
5 years
0.02
Extreme 0.021
7.05
10 years
0.02
Extreme 0.021
14.95
More quotes
Managers TitleAgeSince
Chief Executive Officer 52 08-12-31
Director of Finance/CFO 48 08-12-31
Chief Tech/Sci/R&D Officer 70 04-10-31
Members of the board TitleAgeSince
Director/Board Member 56 08-12-31
Chief Executive Officer 52 08-12-31
Director/Board Member 56 08-12-31
More insiders
Date Price Change Volume
24-04-19 1.25 0.00% 1,788
24-04-12 1.25 -3.85% 2,433
24-04-11 1.3 0.00% 2,331

Delayed Quote OTC Markets, April 19, 2024 at 10:05 am EDT

More quotes
Global Cord Blood Corporation is a provider of cord blood banking services in China. The Company and its subsidiaries are principally engaged in the provision of umbilical cord blood storage and ancillary services in the People's Republic of China. It provides cord blood testing, processing and storage services under the direction of subscribers for a cord blood processing fee and a storage fee. It also tests, processes and stores donated cord blood, and provides matching services to the public for a fee. The Company provides cord blood processing and storage services for expectant parents interested in capturing the opportunities made available by evolving medical treatments and technologies, such as cord blood transplants. It also preserves cord blood units donated by the public; provides matching services on such donated units, and delivers matching units to patients in need of transplants.
More about the company
  1. Stock Market
  2. Equities
  3. CORB.F Stock